Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$39.01
+$0.02 (+0.05%)
Sep 22, 2026, 2:37 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -213.04M | -102.3M | -105.26M | -90.9M | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M | -22.11M | -15.76M |
Depreciation & Amortization | 1.15M | 587K | 611K | 641K | 632K | 659K | 633K | 700K | 659K | 586K | 851K | 1.73M | 602K | 354K | 515K | 358K | 375K | 376K | 270K | 209K | 231K | 196K |
Stock-Based Compensation | 33.63M | 16.89M | 14.12M | 13.71M | 13.71M | 12.17M | 13.6M | 13M | 14.72M | 9.4M | 9.18M | 8.74M | 8.45M | 5.99M | 5.81M | 5.74M | 5.21M | 3.61M | 2.71M | 2.64M | 2.7M | 1.97M |
Other Working Capital | -949K | -1.78M | 6.45M | 4.68M | -5.8M | -1.23M | 2.74M | -239K | 936K | -5.99M | -228K | -3.45M | 6.85M | 2.34M | -449K | -2.41M | 6.5M | -6.07M | -2.2M | -2.24M | 3.26M | -533K |
Other Non-Cash Items | -3.57M | -1.14M | 1.12M | 536K | 3.68M | 3.97M | 3.49M | 67K | 9.27M | -2.7M | -33K | -791K | -1.48M | -1.88M | -2.74M | 3.26M | 1.92M | 3.22M | 523K | 420K | 233K | -130K |
Deferred Income Tax | -1.5M | 447K | -1.11M | -701K | -170K | -1.21M | -8.61M | -322K | -333K | 403K | -200K | -156K | -224K | 288K | 5K | -203K | -104K | 258K | 346K | -267K | -30K | 9K |
Change in Working Capital | -949K | -3.38M | 9.05M | 4.96M | 2.62M | -12.19M | 2.19M | -322K | 936K | -5.95M | -522K | -3.3M | 6.89M | 2.56M | 1.07M | -2.41M | 6.89M | -6.23M | 1.01M | -2.57M | 5.89M | -6.98M |
Operating Cash Flow | -184.29M | -88.9M | -81.48M | -71.75M | -64.23M | -61.65M | -54.39M | -49.67M | -32.68M | -46.19M | -35.47M | -42.23M | -33.22M | -34.41M | -32.73M | -30.4M | -16.87M | -18.43M | -20.71M | -15.01M | -13.08M | -20.71M |
Capital Expenditures | -408K | -133K | -318K | -281K | -157K | -43K | -783K | -590K | -1.51M | -188K | -78K | -1.2M | -2.13M | -2.21M | -1.75M | -386K | -544K | -212K | -514K | -223K | -909K | -404K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.23M | -30.04M | n/a | n/a | n/a | n/a | -20.28M | -144.75M | n/a | n/a | -45.96M |
Purchase of Investments | -996.03M | -505.65M | -60.9M | -74.7M | -88.82M | -131.24M | -66.35M | -164.09M | -124.98M | -176.85M | -376.59M | -146.77M | -162.27M | -108.28M | -114.74M | -294.76M | -72.68M | -68.96M | -257.19M | -10M | -21.62M | -100.66M |
Sales Maturities Of Investments | 257.92M | 98.5M | 337.03M | 113.51M | 171.23M | 165.79M | 165.64M | 165.18M | 237.21M | 133.84M | 136.94M | 196M | 192.31M | 157.11M | 102.16M | 61.04M | 74.54M | 20.28M | 42.28M | 25.8M | 30.73M | 45.96M |
Other Investing Acitivies | n/a | n/a | -213.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49.23M | 30.04M | n/a | n/a | n/a | n/a | 20.28M | 144.75M | n/a | n/a | 45.96M |
Investing Cash Flow | -738.52M | -407.28M | 62.7M | 38.53M | 82.26M | 34.51M | 98.5M | 498K | 110.72M | -43.19M | -239.73M | 48.03M | 27.9M | 46.62M | -14.34M | -234.1M | 1.32M | -48.89M | -215.43M | 15.58M | 8.19M | -55.1M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 837.53M | n/a | -191.75K | -33.48K | -22.2K | n/a | 47K | n/a | n/a | n/a | 35K | n/a | n/a | n/a | 6K | 699K | n/a | n/a | 15K | 28K | 111K | 106K |
Financial Cash Flow | 843.04M | 843.01M | 113.54M | 2.36M | 65K | 1.15M | 12.13M | n/a | n/a | n/a | 324.01M | 29.51M | n/a | n/a | 6K | 699K | 269.89M | 7.88M | 323.95M | 4.76M | 111K | 118.72M |
Net Cash Flow | -79.64M | 346.7M | 94.65M | -30.87M | 18.72M | -26.06M | 55.09M | -49.11M | 77.84M | -89.75M | 49.07M | 35.02M | -4.96M | 12.27M | -46.25M | -266.5M | 253.45M | -59.15M | 87.88M | 4.88M | -5.06M | 42.98M |
Free Cash Flow | -184.7M | -89.03M | -81.8M | -72.03M | -64.39M | -61.7M | -55.17M | -50.26M | -34.19M | -46.38M | -35.54M | -43.43M | -35.35M | -36.62M | -34.48M | -30.79M | -17.41M | -18.64M | -21.22M | -15.23M | -13.99M | -21.11M |
Adj. Free Cash Flow | -218.32M | -105.92M | -95.91M | -85.74M | -78.1M | -73.87M | -68.77M | -63.26M | -48.91M | -55.78M | -44.73M | -52.17M | -43.81M | -42.61M | -40.3M | -36.53M | -22.62M | -22.25M | -23.93M | -17.87M | -16.69M | -23.08M |
Maintenance CapEx | -408K | -133K | -318K | -281K | -157K | n/a | -783K | -590K | -1.51M | -188K | -78K | -1.2M | -2.13M | -2.21M | -1.75M | -386K | -544K | n/a | -514K | n/a | -909K | -404K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -212K | n/a | -223K | n/a | n/a |
Owner Earnings | -184.7M | -89.03M | -81.8M | -72.03M | -64.39M | -61.65M | -55.17M | -50.26M | -34.19M | -46.38M | -35.54M | -43.43M | -35.35M | -36.62M | -34.48M | -30.79M | -17.41M | -18.43M | -21.22M | -15.01M | -13.99M | -21.11M |
Add to Watchlist
Select watchlists to add or remove XENE